Privia Health [PRVA] vs Veeva Systems [VEEV] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Privia Health wins in 6 metrics, Veeva Systems wins in 13 metrics, with 0 ties. Veeva Systems appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPrivia HealthVeeva SystemsBetter
P/E Ratio (TTM)226.3658.89Veeva Systems
Price-to-Book Ratio4.477.24Privia Health
Debt-to-Equity Ratio0.911.29Privia Health
PEG Ratio-6.793.67Privia Health
EV/EBITDA98.2148.87Veeva Systems
Profit Margin (TTM)0.78%27.29%Veeva Systems
Operating Margin (TTM)0.64%28.71%Veeva Systems
EBITDA Margin (TTM)0.64%28.71%Veeva Systems
Return on Equity2.71%13.70%Veeva Systems
Return on Assets (TTM)1.04%7.24%Veeva Systems
Free Cash Flow (TTM)$109.28M$1.09BVeeva Systems
1-Year Return39.06%46.96%Veeva Systems
Price-to-Sales Ratio (TTM)1.6116.19Privia Health
Enterprise Value$2.72B$42.51BVeeva Systems
EV/Revenue Ratio1.4314.32Privia Health
Gross Profit Margin (TTM)9.64%75.26%Veeva Systems
Revenue per Share (TTM)$16$18Veeva Systems
Earnings per Share (Diluted)$0.11$4.98Veeva Systems
Beta (Stock Volatility)0.820.95Privia Health
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Privia Health vs Veeva Systems Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Privia Health-2.08%4.71%5.48%11.59%9.39%24.54%
Veeva Systems2.57%7.45%11.41%6.43%32.78%42.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Privia Health39.06%-28.42%-32.65%-32.65%-32.65%-32.65%
Veeva Systems46.96%81.38%2.27%1,066.76%577.61%577.61%

News Based Sentiment: Privia Health vs Veeva Systems

Privia Health

News based Sentiment: MIXED

September was a pivotal month for Privia Health, featuring a significant acquisition alongside a disappointing earnings report and varied analyst opinions. The acquisition signals a strategic move towards growth, but the profitability concerns and mixed market reaction create a complex investment picture, making it a moderately important month for investors.

View Privia Health News Sentiment Analysis

Veeva Systems

News based Sentiment: POSITIVE

Veeva demonstrated strong financial results and continued expansion of its CRM platform within the biopharma industry, despite a minor stock decline. The upcoming Investor Day presents an opportunity for management to articulate their vision and reinforce investor confidence.

View Veeva Systems News Sentiment Analysis

Performance & Financial Health Analysis: Privia Health vs Veeva Systems

MetricPRVAVEEV
Market Information
Market Cap i$3.07B$48.07B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,125,5901,264,800
90 Day Avg. Volume i839,5571,442,037
Last Close$24.46$300.79
52 Week Range$16.47 - $26.09$200.30 - $300.88
% from 52W High-6.25%-0.03%
All-Time High$50.77 (Jun 28, 2021)$343.96 (Aug 02, 2021)
% from All-Time High-51.82%-12.55%
Growth Metrics
Quarterly Revenue Growth0.23%0.17%
Quarterly Earnings Growth-0.23%0.17%
Financial Health
Profit Margin (TTM) i0.01%0.27%
Operating Margin (TTM) i0.01%0.29%
Return on Equity (TTM) i0.03%0.14%
Debt to Equity (MRQ) i0.911.29
Cash & Liquidity
Book Value per Share (MRQ)$5.57$40.51
Cash per Share (MRQ)$3.18$39.07
Operating Cash Flow (TTM) i$91.86M$1.35B
Levered Free Cash Flow (TTM) i$92.29M$1.10B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Privia Health vs Veeva Systems

MetricPRVAVEEV
Price Ratios
P/E Ratio (TTM) i226.3658.89
Forward P/E i95.7743.38
PEG Ratio i-6.793.67
Price to Sales (TTM) i1.6116.19
Price to Book (MRQ) i4.477.24
Market Capitalization
Market Capitalization i$3.07B$48.07B
Enterprise Value i$2.72B$42.51B
Enterprise Value Metrics
Enterprise to Revenue i1.4314.32
Enterprise to EBITDA i98.2148.87
Risk & Other Metrics
Beta i0.820.95
Book Value per Share (MRQ) i$5.57$40.51

Financial Statements Comparison: Privia Health vs Veeva Systems

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PRVAVEEV
Revenue/Sales i$480.10M$759.04M
Cost of Goods Sold i$434.34M$173.82M
Gross Profit i$45.76M$585.22M
Research & Development iN/A$184.03M
Operating Income (EBIT) i$5.22M$233.73M
EBITDA i$7.12M$243.55M
Pre-Tax Income i$8.15M$298.82M
Income Tax i$2.10M$70.63M
Net Income (Profit) i$6.05M$228.19M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PRVAVEEV
Cash & Equivalents i$469.33M$1.96B
Total Current Assets i$886.47M$6.71B
Total Current Liabilities i$470.81M$1.46B
Long-Term Debt i$3.05M$66.57M
Total Shareholders Equity i$709.53M$6.21B
Retained Earnings i$-175.01M$3.68B
Property, Plant & Equipment i$1.01M$122.23M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PRVAVEEV
Operating Cash Flow i$-9.30M$810.54M
Capital Expenditures iN/AN/A
Free Cash Flow i$-24.06M$877.16M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPRVAVEEV
Shares Short i3.11M5.41M
Short Ratio i4.363.60
Short % of Float i0.05%0.04%
Average Daily Volume (10 Day) i1,125,5901,264,800
Average Daily Volume (90 Day) i839,5571,442,037
Shares Outstanding i120.31M162.58M
Float Shares i98.70M150.41M
% Held by Insiders i0.07%0.09%
% Held by Institutions i0.97%0.89%

Dividend Analysis & Yield Comparison: Privia Health vs Veeva Systems

MetricPRVAVEEV
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.05N/A
3-Year Avg Dividend Yield i0.18%N/A
3-Year Total Dividends i$0.15N/A
Ex-Dividend DateMar 28, 2023N/A